Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19). McCullough PA. Antimicrob Agents Chemother 2020;64.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McCullough PA. Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19). Antimicrob Agents Chemother 2020;64.
PMID: 32967849